Global Edible Fungus Market Trends and Insights
High consumer shift to plant-based proteins
As dietary preferences shift toward plant-based proteins, fungi are becoming a preferred source, offering all nine essential amino acids and achieving protein densities of up to 22% on a dry-matter basis. In 2025, Enifer made a notable move by submitting its PEKILO mycoprotein to the FDA for a Generally Recognized as Safe (GRAS) designation. With a target composition of 50% protein and 35% fiber, PEKILO is designed to replace soy isolates in meat alternatives. This regulatory milestone highlights a broader trend in the food industry: manufacturers are expanding their protein sources to reduce reliance on soy and address concerns over price volatility and allergens. Retail data reflects this shift: in 2024, U.S. per-capita mushroom availability reached 3.5 pounds, with organic mushrooms accounting for 8% of the volume despite higher prices. In May 2025, innovations such as texturized pea-shiitake protein blends, developed through high-moisture extrusion, demonstrated fungi's potential to improve mouthfeel and umami flavor in plant-based products. These advancements tackle the texture issues that previously limited consumer acceptance. The rising vegan population is further driving mushroom demand, as seen in the UK, where the number of vegans increased by 1.1 million between 2023 and 2024, reaching 2.5 million or approximately 4.7% of the adult population, according to the Jewish, Vegan, Sustainable Organization.Rising health consciousness and functional food adoption
Specialty mushrooms are evolving from culinary ingredients to therapeutic adjuncts, driven by clinical evidence that links their bioactive compounds to immune modulation and neuroprotection. In 2024, the US Department of Agriculture reported that per capita fresh mushroom consumption in the United States reached 3.3 pounds. Human trials have demonstrated that Hericium erinaceus, at doses of up to 1 gram per day for 16 weeks, stimulates nerve growth factor pathways and improves mild cognitive impairment scores. Preclinical studies have revealed the hypoglycemic and anticancer potential of Ganoderma lucidum's triterpenes and polysaccharides, prompting supplement manufacturers to standardize ganoderic acid content. Reflecting the industry's focus on quality-controlled extracts, Real Mushrooms acquired Mushroom Science in February 2026, consolidating two leading functional supplement brands. Controlled studies have also shown that shiitake polysaccharides can mitigate obesity-related cognitive impairment by modulating the gut microbiota, emphasizing the importance of the gut-brain axis.Short shelf-life and post-harvest losses
Perishability is a critical challenge for the sector. Fresh mushrooms, for example, have a shelf life of less than four days at ambient temperatures, and post-harvest losses can reach up to 50% in regions without refrigerated logistics. FAO data indicates that global post-harvest losses from harvest to retail average 13.8%. However, in Sub-Saharan Africa, fruits and vegetables experience losses ranging from 20-50%, with mushrooms being particularly affected due to their high moisture content and susceptibility to enzymatic browning. On-site cold storage can reduce losses by 13.2 percentage points, but the significant capital investment required for refrigeration infrastructure excludes smallholder producers in emerging markets. This issue is further exacerbated by the fact that mushrooms achieve premium pricing only when they remain visually pristine. Quality degradation within 48 hours of harvest often forces growers to either discount or discard their produce. To address this, growers are adopting modified-atmosphere packaging, which extends shelf life to 7-10 days, and are utilizing dehydration or freeze-drying techniques to stabilize products for export markets. However, these measures increase production costs by 15-25%, compressing margins unless retail prices are adjusted upward.Other drivers and restraints analyzed in the detailed report include:
- Expansion of cold-chain and retail infrastructure in emerging economies
- Technological innovations in controlled-environment agriculture
- Energy and raw-material price volatility
Segment Analysis
In 2025, conventional production held a commanding 83.26% market share, thanks to its cost advantages and well-established supply chains that ensure consistent quality at scale. Growers using conventional methods leverage synthetic fertilizers and pesticides, boosting yields and curbing crop losses. This strategy allows them to set price points that appeal to the mass market. On the other hand, organic cultivation is on an upward trajectory, projected to grow at 7.84% through 2031. This growth is attributed to maturing certification frameworks and the ability to command premium prices, even if it means accepting lower yields. In 2024, U.S. organic mushrooms accounted for 8% of the volume, a dip from the 9-10% range in previous years. Notably, Agaricus varieties made up 80% of this organic volume, underscoring the dominance of button mushrooms in certified production.The organic segment grapples with a structural challenge: the certification process mandates a 3-year transition period. During this time, growers bear the costs of organic inputs but miss out on premium pricing, leading to cash-flow challenges that can sideline smaller operators. Moreover, integrated pest management systems, which swap out synthetic fungicides for biological controls, necessitate increased labor and agronomic expertise, driving up costs. Despite these challenges, consumers, especially in North America and Europe, continue to pay a premium for organic mushrooms. Their willingness is fueled by health perceptions and environmental concerns, with organic foods making up over 10% of grocery spending in these regions. While conventional production thrives in price-sensitive markets and foodservice channels, where cost per serving is paramount, organic growers in Europe tap into premium retail channels and direct-to-consumer sales, justifying their higher production costs. Meanwhile, in the Asia-Pacific, conventional producers benefit from low labor costs and intensive substrate formulations.
In 2025, button mushrooms captured 60.39% of the market, thanks to their versatile flavor, ease of mechanical harvesting, and established roles in pizzas, pastas, and burgers. Decades of selective breeding have enhanced button mushrooms' yield, disease resistance, and shelf life, establishing a cost advantage that's tough for competitors to challenge. Meanwhile, reishi mushrooms are on a growth trajectory, projected to rise at 7.29% through 2031. This surge is fueled by mounting clinical evidence linking triterpenes to benefits in neurological health and immune modulation. A May 2025 review in Nutrients highlighted the hypoglycemic and anticancer properties of Ganoderma lucidum polysaccharides in preclinical models, prompting supplement manufacturers to standardize ganoderic acid content.
The intersection of functional mushrooms and nutraceuticals is becoming pronounced: In April 2026, Vietnam began commercializing reishi products, including dried mushrooms, extracts, and wine sourced from Ta Dung National Park. Additionally, intercropping pilots beneath cashew trees produced a yield of 128 kilograms, fetching 250,000 VND per kilogram. This diversification is reshaping the market landscape, with growers gravitating towards varieties that resonate with regional culinary traditions or health claims, rather than merely competing on the price of commodity button mushrooms.
Complete Report Scope:
- By Category
- Organic
- Conventional
- By Mushroom Type
- Button Mushroom
- Shiitake
- Oyster
- Reishi
- Enoki
- Other Types
- By Form
- Fresh
- Frozen
- Dried
- Canned
- Other Processed Form
- By Distribution Channel
- On-Trade
- Off-Trade
- Supermarkets and Hypermarkets
- Convenience and Grocery Stores
- Online Retail Stores
- Other Distribution Channel
- By Geography
- North America
- United States
- Canada
- Mexico
- Rest of North America
- Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Russia
- Sweden
- Belgium
- Poland
- Netherlands
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Thailand
- Singapore
- Indonesia
- South Korea
- Australia
- New Zealand
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Colombia
- Chile
- Rest of South America
- Middle East and Africa
- United Arab Emirates
- South Africa
- Saudi Arabia
- Nigeria
- Egypt
- Morocco
- Turkey
- Rest of Middle East and Africa
- North America
Geography Analysis
In 2025, Asia-Pacific, driven by substantial production in China, Japan, and India, contributed 50.47% of the global revenue. India, Thailand, and Indonesia are significantly increasing their production capacities to meet both domestic consumption and export demands. However, the region faces notable challenges. Japan experienced an 8.0% decline in its producer count in 2025, underscoring persistent labor shortages. Furthermore, rising energy costs have led to inflation, which has compressed profit margins, particularly for substrate cultivation processes that require climate-controlled environments.The Middle East and Africa region stands out as the fastest-growing market, with a compound annual growth rate (CAGR) of 8.01%. Cold-chain infrastructure developments in the UAE and Saudi Arabia are playing a pivotal role in extending the shelf life of products and facilitating smoother import operations. In Nigeria, pilot farming initiatives have demonstrated that mushroom intercropping can generate an additional income of USD 7,406 per hectare compared to millet cultivation. Despite these advancements, the region continues to face significant hurdles, as inadequate infrastructure remains a bottleneck. In some sub-Saharan areas, spoilage rates still exceed 40%, highlighting the need for further investment in logistics and storage solutions.
In 2024, North America recorded an output of 669.9 million lb, valued at USD 1.1 billion. Pennsylvania emerged as the leading contributor, supplying 69% of the Agaricus mushrooms in the region. Canada fulfilled 25% of U.S. consumption through imports, while Mexico is actively scaling up its production capacity to offer cost-competitive fresh exports. In Europe, Germany produced 75,700 tonnes of mushrooms in 2024, with 98% of the output being button mushrooms. However, the number of growers in the region has dwindled to just 25, primarily due to challenges related to labor shortages and escalating energy costs. In South America, Brazil and Chile are driving market expansion, but the region faces a critical need for consumer education to shift mushrooms from being perceived as a specialty product to becoming a staple food item.
List of Companies Covered in this Report:
- Monaghan Mushrooms
- Bonduelle Group
- Giorgio Fresh Co.
- Costa Group
- Shanghai Finc Bio-Tech
- Monterey Mushrooms
- Highline Mushrooms
- Phillips Mushroom Farms
- South Mill Champs
- The Mushroom Company
- Okechamp S.A.
- Greenyard (Lutece)
- Modern Mushroom Farms
- Banken Champignons
- Ecolink Baltic
- B and G Foods (Canned)
- Xiaxi Fudeng Biotechnology
- Ruyiqing Mushroom Co.
- Carleton Mushroom Farms
- Lianfeng (Suizhou) Food
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Monaghan Mushrooms
- Bonduelle Group
- Giorgio Fresh Co.
- Costa Group
- Shanghai Finc Bio-Tech
- Monterey Mushrooms
- Highline Mushrooms
- Phillips Mushroom Farms
- South Mill Champs
- The Mushroom Company
- Okechamp S.A.
- Greenyard (Lutece)
- Modern Mushroom Farms
- Banken Champignons
- Ecolink Baltic
- B and G Foods (Canned)
- Xiaxi Fudeng Biotechnology
- Ruyiqing Mushroom Co.
- Carleton Mushroom Farms
- Lianfeng (Suizhou) Food

